106 related articles for article (PubMed ID: 13678737)
1. Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH.
Israeli O; Gotlieb WH; Friedman E; Goldman B; Ben-Baruch G; Aviram-Goldring A; Rienstein S
Gynecol Oncol; 2003 Sep; 90(3):629-36. PubMed ID: 13678737
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.
Patael-Karasik Y; Daniely M; Gotlieb WH; Ben-Baruch G; Schiby J; Barakai G; Goldman B; Aviram A; Friedman E
Cancer Genet Cytogenet; 2000 Aug; 121(1):26-32. PubMed ID: 10958937
[TBL] [Abstract][Full Text] [Related]
3. BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Ramus SJ; Pharoah PD; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BA; Gayther SA
Cancer Res; 2003 Jan; 63(2):417-23. PubMed ID: 12543797
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors.
Johannsdottir HK; Jonsson G; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Heikkila P; Egilsson V; Olsson H; Johannsson OT; Nevanlinna H; Borg A; Barkardottir RB
Int J Cancer; 2006 Sep; 119(5):1052-60. PubMed ID: 16570289
[TBL] [Abstract][Full Text] [Related]
5. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
[TBL] [Abstract][Full Text] [Related]
6. Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors.
Gotlieb WH; Friedman E; Bar-Sade RB; Kruglikova A; Hirsh-Yechezkel G; Modan B; Inbar M; Davidson B; Kopolovic J; Novikov I; Ben-Baruch G
J Natl Cancer Inst; 1998 Jul; 90(13):995-1000. PubMed ID: 9665148
[TBL] [Abstract][Full Text] [Related]
7. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.
Tirkkonen M; Johannsson O; Agnarsson BA; Olsson H; Ingvarsson S; Karhu R; Tanner M; Isola J; Barkardottir RB; Borg A; Kallioniemi OP
Cancer Res; 1997 Apr; 57(7):1222-7. PubMed ID: 9102202
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in Israel.
Ravid A; Barshack I; Hirsh-Yechezkel G; Goldberg I; Bar-Sade RB; Chetrit A; Reder I; Ben-Baruch G; Gotlieb WH; Kopolovic J; Friedman E
Eur J Cancer; 2000 Jun; 36(9):1120-4. PubMed ID: 10854945
[TBL] [Abstract][Full Text] [Related]
9. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
van Beers EH; van Welsem T; Wessels LF; Li Y; Oldenburg RA; Devilee P; Cornelisse CJ; Verhoef S; Hogervorst FB; van't Veer LJ; Nederlof PM
Cancer Res; 2005 Feb; 65(3):822-7. PubMed ID: 15705879
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.
Wessels LF; van Welsem T; Hart AA; van't Veer LJ; Reinders MJ; Nederlof PM
Cancer Res; 2002 Dec; 62(23):7110-7. PubMed ID: 12460933
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma.
Zweemer RP; Ryan A; Snijders AM; Hermsen MA; Meijer GA; Beller U; Menko FH; Jacobs IJ; Baak JP; Verheijen RH; Kenemans P; van Diest PJ
Lab Invest; 2001 Oct; 81(10):1363-70. PubMed ID: 11598149
[TBL] [Abstract][Full Text] [Related]
12. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
[TBL] [Abstract][Full Text] [Related]
14. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
[TBL] [Abstract][Full Text] [Related]
15. Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.
George J; Alsop K; Etemadmoghadam D; Hondow H; Mikeska T; Dobrovic A; deFazio A; ; Smyth GK; Levine DA; Mitchell G; Bowtell DD
Clin Cancer Res; 2013 Jul; 19(13):3474-84. PubMed ID: 23633455
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
[TBL] [Abstract][Full Text] [Related]
17. DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas.
Kamieniak MM; Muñoz-Repeto I; Rico D; Osorio A; Urioste M; García-Donas J; Hernando S; Robles-Díaz L; Ramón Y Cajal T; Cazorla A; Sáez R; García-Bueno JM; Domingo S; Borrego S; Palacios J; van de Wiel MA; Ylstra B; Benítez J; García MJ
Br J Cancer; 2013 Apr; 108(8):1732-42. PubMed ID: 23558894
[TBL] [Abstract][Full Text] [Related]
18. Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer.
Gershoni-Baruch R; Dagan E; Fried G; Bruchim Bar-Sade R; Sverdlov-Shiri R; Zelicksson G; Friedman E
Eur J Cancer; 2000 May; 36(8):983-6. PubMed ID: 10885601
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
20. Genomic rearrangements in the BRCA1 and BRCA2 genes.
Mazoyer S
Hum Mutat; 2005 May; 25(5):415-22. PubMed ID: 15832305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
